Novel Method Development and Validation of Brexpiprazole in Bulk and Pharmaceutical Formulation by RP-HPLC Method
Objective: To develop and validate a simple, accurate, precise, and rapid method for estimation of Brexpiprazole pharmaceutical formulations using RP-HPLC. Methods: High-Performance liquid chromatography was used to analyse Brexpiprazole. The separation was performed on COSMICSIL, (150 X 4.6mm, 5μm) at room temperature using NaH2PO4 and methanol in equal volumes in isocratic condition at a flow rate of 1.0 mL/min. The detection was performed by an ultraviolet detector (UVD) at 215 nm with total run time of 5 min. Calibration curves were linear in the concentration range of 2-6 μg/mL. Results: Brexpiprazole retention time (Rt) was discovered to be 2.25 minutes. Linearity calibration plot was plotted in the concentration range of 2–6 μg/mL for Brexpiprazole with linear regression equation of y = 78453x - 2454.2 (R² = 1). The precision studies were estimated, the results were calculated as percentage RSD values, and the % RSD was calculated and obtained as 1.10 for Brexpiprazole in precision study. The %RSD was found to be with in the acceptance limit of < 2. Brexpiprazole mean Recovery was determined to be 99.14%, confirming the effectiveness of the procedure. Conclusion: According to ICH criteria, the designed RP-HPLC technique was verified. Brexpiprazole can be analysed using the established approach in both its bulk and commercial form. Major Findings: A simple, rapid, and precise RP-HPLC method was developed and validated for Brexpiprazole estimation with excellent linearity (R² = 1), precision (%RSD = 1.10), and accuracy (99.14% recovery). The retention time was 2.25 minutes, ensuring quick analysis. This method can be used for routine quality control and stability studies of Brexpiprazole formulations.